This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Automated CT-based AI tools can visualize biomarkers of body composition changes in patients using Ozempic (semaglutide) for diabetes type 2 treatment or obesity, according to a study published September 10 in the American Journal of Roentgenology. These changes are beyond what can be evaluated by clinical measures such as weight and waist circumference, wrote a team led by Leslie W.
In The Happiness Hypothesis , Jonathan Haidt describes work by William Damon at Stanford that sought “to see why some professions seemed healthy while others were growing sick”: Picking the fields of genetics and journalism as case studies, they conducted dozens of interviews with people in each field. Their conclusion is as profound as it is simple: It’s a matter of alignment.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
U.S. Rep. Rosa DeLauro, D-Conn., convened the hearing a day before new FDA breast density notification requirements were set to go into effect on Sept. 10.
A PET radiotracer that detects clear-cell renal cell carcinoma proved safe and effective in a clinical trial conducted at 36 research hospitals across nine countries, according to a study published September 10 in the Lancet Oncology. The imaging agent fills an unmet need to identify small lesions, which could allow earlier diagnosis of the disease, noted lead author Brian Shuch, MD, of the University of California, Los Angeles, and colleagues.
Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
The feds see this as a way of increasing specialist engagement in value-based care and bolstering their collaboration with PCPs and Medicare beneficiaries.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Editor's note: As part of the celebration of AuntMinnie.com's upcoming 25th anniversary, we're presenting 25 for 25 -- a series featuring our most popular content for each of the last 25 years. New articles will be published each Monday until our official anniversary at RSNA 2024. Our top article in 2012 reported on mainstream media attention to the use af “recalls” by radiology residents to prepare for board exams.
Imagine building a traffic surveillance camera that could detect trouble-making cells speeding around in your brain before their cellular gang could commit "crimes." Most importantly, this camera could catch some of the biggest interlopers of all—cancer cells.
Moving away from a "one size fits all" approach to one that targets women at greater risk of developing the disease could help the UK's NHS better allocate scarce screening resources, experts wrote.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
A newly developed contrast-enhanced ultrasound (CEUS) Vesical Imaging-Reporting and Data System (VI-RADS) helps both novice and expert readers to evaluate muscle-invasive bladder cancer (MIBC), researchers reported September 10 in Radiology. "Contrast-enhanced ultrasound (CEUS) with microbubbles makes it possible to clearly identify and assess the three-layer structure of bladder wall by means of real-time perfusion imaging," noted a team led by Jing Han, MD, of the Sun Yat-sen University Cancer
Researchers have published a novel study exploring the effects of delayed feedback on learning in individuals with moderate-to-severe traumatic brain injury. The goal of this study was to assess the effects of delayed vs. immediate performance feedback on learning in individuals with TBI and to examine the associated brain networks.
Debra L. Monticciolo, MD, past president of both the Society of Breast Imaging, and the American College of Radiology, explains the advantages and disadvantages of current breast screening technology.
Such tools can be especially beneficial for trainees working after-hours shifts, when quality feedback is generally delayed and more difficult to come by.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Ultrasound shows that young people who vape -- even if they have no apparent signs of lung damage -- have lower capacity for exercise, according to research presented September 8 at the European Respiratory Society (ERS) Congress in Vienna, Austria. The study "adds to growing evidence that long-term use of vaping is harmful and challenges the idea that vaping could be a healthier alternative to smoking," the ERS said in a statement.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
September 10 marks a big day in breast health as the federal mandate on breast density notification takes effect. The mandate, part of the U.S. Food and Drug Administration’s (FDA) Mammography Quality Standards Act (MQSA), requires health providers to notify women of their breast density. Breast imaging advocates have applauded the mandate since the FDA announced its planned implementation in 2023.
A technology which uses harmless light waves to measure activity in babies' brains has provided the most complete picture to date of brain functions like hearing, vision and cognitive processing outside a conventional, restrictive brain scanner.
CMS first started allowing this perk in response to the COVID-19 pandemic, with providers able to oversee exams using real-time audio and visual technology.
Although LLMs have seen rapid advancement in recent years, they still cannot compare to human radiologists when it comes to staging cancer using free text reports.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content